TY - JOUR
T1 - Worldwide expert recommendations for the diagnosis and management of vitiligo
T2 - Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm
AU - van Geel, Nanja
AU - Speeckaert, Reinhart
AU - Taïeb, Alain
AU - Ezzedine, Khaled
AU - Lim, Henry W.
AU - Pandya, Amit G.
AU - Passeron, Thierry
AU - Wolkerstorfer, Albert
AU - Abdallah, Marwa
AU - Alomar, Augustin
AU - Bae, Jung Min
AU - Bekkenk, Marcel
AU - Benzekri, Laila
AU - Böhm, Markus
AU - Eleftheriadou, Viktoria
AU - Esmat, Samia
AU - Ghia, Deepti
AU - Goh, Boon Kee
AU - Grimes, Pearl
AU - Gupta, Somesh
AU - Hamzavi, Iltefat H.
AU - Harris, John E.
AU - Oh, Sang Ho
AU - Huggins, Richard
AU - Katayama, Ichiro
AU - Lan, Eric
AU - Lee, Ai-Young
AU - Leone, Giovanni
AU - le Poole, Caroline
AU - Lui, Harvey
AU - Maquignon, Nicolle
AU - Meurant, Jean Marie
AU - Monteiro, Paul
AU - Oiso, Naoki
AU - Parsad, Davinder
AU - Pliszewski, Georg
AU - Raboobee, Noufal
AU - Rodrigues, Michelle
AU - Rosmarin, David
AU - Suzuki, Tamio
AU - Tanemura, Atsushi
AU - Thng, Steven
AU - Xiang, Flora
AU - Zhou, Youwen
AU - Picardo, Mauro
AU - Seneschal, Julien
N1 - Funding Information: We are grateful to all the participating patient representatives and vitiligo experts who attended the VTF meetings, VIPOC meetings, and final VTF conclusive consensus meeting in Milan (EADV 2022). We express our deep gratitude to all patient representatives who played a significant role in the development of this work through their dedicated involvement in the process (JMM, NM, PM, GP). Publisher Copyright: © 2023 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
PY - 2023/11
Y1 - 2023/11
N2 - Background: The treatment of vitiligo can be challenging and depends on several factors such as the subtype, disease activity, vitiligo extent, and treatment goals. Vitiligo usually requires a long-term approach. To improve the management of vitiligo worldwide, a clear and up-to-date guide based on international consensus with uniform stepwise recommendations is needed. Objectives: To reach an international consensus on the nomenclature and to develop a management algorithm for the diagnosis, assessment, and treatment of vitiligo. Methods: In this consensus statement, a consortium of 42 international vitiligo experts and four patient representatives participated in online and live meetings to develop a consensus management strategy for vitiligo. At least two vitiligo experts summarized the evidence of topics included in the algorithms. A survey was utilized to resolve remaining issues among a core group of eight experts. Subsequently, the unanimous recommendations were finalized and validated based on further input from the entire group during two live meetings. Results: The algorithms highlight the importance of shared decision-making. Dermatologists are encouraged to provide patients with detailed explanations of the prognosis and expected therapeutic outcomes based on clinical examination. The treatment goal should be discussed and clearly emphasized to patients given the different approaches for disease stabilization and repigmentation. The evaluation of disease activity remains a cornerstone in the tailor-made approach to vitiligo patients. Conclusions: These new treatment algorithms are intended to guide clinical decision-making in clinical practice. Promising novel therapies for vitiligo are on the horizon, further highlighting the need for reliable outcome measurement instruments and greater emphasis on shared decision-making.
AB - Background: The treatment of vitiligo can be challenging and depends on several factors such as the subtype, disease activity, vitiligo extent, and treatment goals. Vitiligo usually requires a long-term approach. To improve the management of vitiligo worldwide, a clear and up-to-date guide based on international consensus with uniform stepwise recommendations is needed. Objectives: To reach an international consensus on the nomenclature and to develop a management algorithm for the diagnosis, assessment, and treatment of vitiligo. Methods: In this consensus statement, a consortium of 42 international vitiligo experts and four patient representatives participated in online and live meetings to develop a consensus management strategy for vitiligo. At least two vitiligo experts summarized the evidence of topics included in the algorithms. A survey was utilized to resolve remaining issues among a core group of eight experts. Subsequently, the unanimous recommendations were finalized and validated based on further input from the entire group during two live meetings. Results: The algorithms highlight the importance of shared decision-making. Dermatologists are encouraged to provide patients with detailed explanations of the prognosis and expected therapeutic outcomes based on clinical examination. The treatment goal should be discussed and clearly emphasized to patients given the different approaches for disease stabilization and repigmentation. The evaluation of disease activity remains a cornerstone in the tailor-made approach to vitiligo patients. Conclusions: These new treatment algorithms are intended to guide clinical decision-making in clinical practice. Promising novel therapies for vitiligo are on the horizon, further highlighting the need for reliable outcome measurement instruments and greater emphasis on shared decision-making.
UR - http://www.scopus.com/inward/record.url?scp=85173063720&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/jdv.19451
DO - https://doi.org/10.1111/jdv.19451
M3 - Article
C2 - 37746876
SN - 0926-9959
VL - 37
SP - 2173
EP - 2184
JO - Journal of the European Academy of Dermatology and Venereology
JF - Journal of the European Academy of Dermatology and Venereology
IS - 11
ER -